Mr Steven Bizar > Dechert LLP > New York, United States > Lawyer Profile

Dechert LLP handles merger clearances for public companies, private equity funds, and their portfolio companies, combining work on HSR filings and joint venture approvals with notable litigation capabilities and regular roles representing third-party challengers to high-profile mergers in proceedings brought by the FTC and DOJ, as well as before international antitrust regulators and state attorneys general. The team has broad sector expertise, with notable involvements in the retail, healthcare, and energy industries, with practice co-head Mike Cowie  a go-to for contentious merger work in the life sciences and healthcare space, and a former FTC official alongside James A Fishkin , who has in-agency experience of merger trials. Steven Bizar  co-leads the team from Philadelphia, while Shari Ross Lahlou is noted for her expertise in investigations and merger-related litigation, and Rani Habash  continues to expand his reputation with regular work for major healthcare clients such as CVS Health and Aetna. The team was bolstered by the February 2023 arrival of the experienced Jay Jurata, a specialist in tech platforms deals, from Orrick, Herrington & Sutcliffe LLP. Lawyers are in Washington DC unless otherwise stated.

Dechert LLP offers global and nationwide antitrust capabilities to its growing client base which features names such as Endo Pharmaceuticals and Marriott International. The firm is well-versed with a range of litigation including conspiracies related to advertising, bid rigging and price fixing as well as antitrust patent litigation and rule of reason standards. Based in Philadelphia is co-head Steven Bizar, who focuses his practice on trial work, particularly antitrust and trade regulation and is well-regarded for his success in defending against section 1 and 2 Sherman Act cases and class action lawsuits. Also co-heading the team from Washington DC is Mike Cowie, a healthcare and life sciences law expert who focuses on government merger investigations and litigation. Also in Philadelphia are George G Gordon who has significant experience in representing companies in class actions and investigations concerning patent enforcement, pricing concerns and marketing, and Julia Chapman, who is well-versed in all stages of litigation particularly in the life sciences, specialty chemicals and tech fields. Experienced trial lawyer Shari Ross Lahlou, based in DC, acts for Fortune 500 clients including Johnson & Johnson. The group has expanded its team and strengthened its high-tech antitrust expertise with the hires from Orrick, Herrington & Sutcliffe LLP in January 2023 including Jay Jurata in DC, former head of Orrick’s antitrust and competition group, Russell Cohen and Howard Ullman in the San Francisco office.

Dechert LLP fields a team of specialized litigators who are regularly engaged to handle disputes arising out of commercial agreements, consumer fraud, insurance and banking, false advertising, corporate governance and mergers and acquisitions-related claims. The trials, investigations and securities team is led by Catherine Botticelli in Washington DC and Jonathan Streeter in New York. Also in New York, Christina Sarchio  is well versed in the consumer products, financial, oil and gas, pharmaceutical, sports and transportation industries, while Linda Goldstein focuses on claims brought by institutional investors and customer arbitrations. New York’s Gary Mennitt co-chairs the international insolvency litigation group, while Steven Bizar co-heads the antitrust/competition practice, operating between New York and Philadelphia.